Skip to content

Redox Determinants of Severe Asthma (a Substudy of the Severe Asthma Research Program)

Redox Determinants of Severe Asthma: A Substudy of the NHLBI Severe Asthma Research Program

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00590005
Acronym
SARP
Enrollment
225
Registered
2008-01-10
Start date
2003-01-31
Completion date
2011-06-30
Last updated
2014-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

severe asthma, poorly controlled asthma

Brief summary

Hypotheses: 1) Airway pH regulation is abnormal in severe asthma; 2) In severe asthma, there is formation of cytotoxic nitrogen oxides and loss of beneficial nitrogen oxides in the airways

Detailed description

Specific Aim 1:Test hypothesis that airway pH regulation is abnormal in severe asthma. 1a) Determine the effects of systemic corticosteroids on breath pH in children with severe and mild to moderate asthma. 1b) Examine whether breath condensate pH and other biomarkers of oxidant stress can predict clinical outcomes in children with severe and mild to moderate asthma. 1c) Identify whether increased Th1/Th2 cytokine ratio, and abnormalities in airway glutaminase, G-SNO-reductase, VATPase, and carbonic anhydrase are associated with airway pH disturbance in children with severe asthma. 1d) Test whether rhinovirus infections, which reduce airway pH, persist longer or are more frequent in children with severe asthma than in children with mild to moderate asthma. 1e) Examine the relationship between gastroesophageal reflux and proximal airway pH in children with severe asthma and mild to moderate asthma.

Interventions

None listed

Sponsors

The Cleveland Clinic
CollaboratorOTHER
Emory University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

* At least 6 years old * Asthma diagnosis by physician * Current treatment with an inhaled corticosteroid medication

Exclusion criteria

* Bronchiectasis * Cystic Fibrosis * Chronic Obstructive Pulmonary Disease

Design outcomes

Primary

MeasureTime frameDescription
Exhaled Nitric Oxide at Baseline and Over the Observational Periodbaseline and after 21 daysExhaled nitric oxide concentrations as measured by collection of exhaled breath into a mylar bag

Secondary

MeasureTime frameDescription
Reduction in Breath pHbaseline and 21 daysBreath condensate pH was measured by the RTube (trademark) device. This device is a plastic tube with a one-way exhalation valve and a chilled aluminum sleeve. pH (the log of hydrogen ion concentration) was measured using an Orion pH meter and probe calibrated in 4.0, 7.0, and 10.0 pH solutions.

Countries

United States

Participant flow

Recruitment details

Children were recruited from January 2003 to June 2011 from the Emory Children's Center asthma clinic.

Pre-assignment details

Children with physician diagnosed asthma were enrolled and underwent comprehensive phenotypic characterization consisting of pulmonary function measures, biomarker assessment, and allergy assessment.

Participants by arm

ArmCount
Children With Asthma
The cohort consists of children with physician-diagnosed asthma across a wide range of severity (mild, moderate, severe)
225
Total225

Baseline characteristics

CharacteristicChildren With Asthma
Age, Categorical
<=18 years
225 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Age, Continuous11.8 years
STANDARD_DEVIATION 3.6
Region of Enrollment
United States
225 participants
Sex: Female, Male
Female
102 Participants
Sex: Female, Male
Male
123 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1060 / 119
serious
Total, serious adverse events
0 / 1060 / 119

Outcome results

Primary

Exhaled Nitric Oxide at Baseline and Over the Observational Period

Exhaled nitric oxide concentrations as measured by collection of exhaled breath into a mylar bag

Time frame: baseline and after 21 days

Population: 225 children were enrolled into the study and completed baseline assessments. Only 40 children were followed longitudinally. The results from only those 40 children are shown here.

ArmMeasureGroupValue (MEAN)Dispersion
Children With Severe AsthmaExhaled Nitric Oxide at Baseline and Over the Observational PeriodExhaled nitric oxide value at 21 days15.1 parts per billionStandard Deviation 5.4
Children With Severe AsthmaExhaled Nitric Oxide at Baseline and Over the Observational PeriodExhaled nitric oxide baseline value13.7 parts per billionStandard Deviation 7.4
Children With Non-severe AsthmaExhaled Nitric Oxide at Baseline and Over the Observational PeriodExhaled nitric oxide baseline value8.6 parts per billionStandard Deviation 6.2
Children With Non-severe AsthmaExhaled Nitric Oxide at Baseline and Over the Observational PeriodExhaled nitric oxide value at 21 days9.9 parts per billionStandard Deviation 5.8
Secondary

Reduction in Breath pH

Breath condensate pH was measured by the RTube (trademark) device. This device is a plastic tube with a one-way exhalation valve and a chilled aluminum sleeve. pH (the log of hydrogen ion concentration) was measured using an Orion pH meter and probe calibrated in 4.0, 7.0, and 10.0 pH solutions.

Time frame: baseline and 21 days

Population: 225 children with asthma were enrolled in the study and completed baseline assessments. Only 40 children were followed longitudinally. The data from those 40 children are shown here.

ArmMeasureGroupValue (MEAN)Dispersion
Children With Severe AsthmaReduction in Breath pHBreath pH at 21 days7.08 log of hydrogen ion concentration (pH)Standard Deviation 0.52
Children With Severe AsthmaReduction in Breath pHBreath pH at baseline7.68 log of hydrogen ion concentration (pH)Standard Deviation 0.69
Children With Non-severe AsthmaReduction in Breath pHBreath pH at 21 days7.58 log of hydrogen ion concentration (pH)Standard Deviation 0.32
Children With Non-severe AsthmaReduction in Breath pHBreath pH at baseline7.63 log of hydrogen ion concentration (pH)Standard Deviation 0.88

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026